HPSE and neoplasm: Priming mice in vivo with human heparanase peptides (Hpa525, Hpa277, and Hpa405) generated CTLs that specifically targeted human tumor cell lines presenting heparanase on either HLA-A*0201 (87) or HLA-A2 (88) (Figure 1E).